Takao Koike

机构：Institute for Rheumatic Diseases (Japan), Center for Rheumatology

发表论文 457 篇 · 总被引 18160 次 · h-index 66

代表论文

• The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression (2015 · Annals of the Rheumatic Diseases · 被引 116)
• Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis (2015 · Modern Rheumatology · 被引 99)
• Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study (2018 · Modern Rheumatology · 被引 77)
• High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study (2017 · Arthritis Research & Therapy · 被引 77)
• Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan (2016 · Modern Rheumatology · 被引 64)
• Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease‐modifying antirheumatic drugs (2018 · International Journal of Rheumatic Diseases · 被引 61)